Skip to main content

Table 1 Summary of analyzed genes, genetic variants and the associated autosomal dominant (AD) diseases

From: Driving mosaicism: somatic variants in reference population databases and effect on variant interpretation in rare genetic disease

Characteristics

AD conditions

All*

Severe and early onset**

Severe and early onset, allelic imbalance***

Number of gene–disease associations

394

77

23

Number of AD diseases

390

76

23

Number of genes

353

72

21

Number of genes per AD disease

1–2

1–2

1

AD diseases, %β

   

1–1

1.8

9.1

17.4

1–2

13.5

68.8

60.9

2–1

0.5

2.6

4.3

2–2

3.8

19.5

17.4

Number of variants

664

115

30

Number of variants per AD disease

1–16

1–9

1–3

AD variants, %

   

PubMed articles

   

> 1 peer-reviewed publication

60.4

67.0

80.0

1 peer-reviewed publication

39.6

33.0

20.0

Variant type

   

Intron

0.3

-

-

Missense

76.7

80.0

80.0

Nonsense

16.4

14.8

16.7

Splice acceptor

2.4

3.5

-

Splice donor

3.3

1.7

3.3

Synonymous

0.8

-

-

Non-coding transcript exon

0.1

-

-

ClinVar classification

   

Pathogenic

79.7

83.5

90.0

Pathogenic/likely pathogenic

7.1

8.7

10.0

Likely pathogenic

13.2

7.8

-

  1. *AD conditions with ClinVar pathogenic and likely pathogenic ClinVar variants in ExAC (Additional file 1: Table S2)
  2. **Severe and early onset AD diseases with ClinVar pathogenic and likely pathogenic variants in ExAC (Additional file 1: Table S3)
  3. ***Severe and early onset AD diseases with ClinVar pathogenic and likely pathogenic variants in ExAC with some evidence of allelic imbalance (at least one allele was found with < 35% of read support; Additional file 1: Table S3). Nine of these genes have evidence of mosaicism (at least two alleles show signs of somatic origin (allelic imbalance))
  4. βAge of onset—Severity. Age of onset score 1 means congenital or very early (< 2 years), age of onset score 2 means mostly early (< 18 years) + variable, severity score 1 means severe, significantly reduced mobility or increased mortality in early life, and severity score 2 means severe plus variable expressivity